Cargando…

The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis

To identify microRNAs (miRNAs, miRs) with potential roles in lung fibrogenesis, we performed genome-wide profiling of miRNA expression in lung tissues from a silica-induced mouse model of pulmonary fibrosis using microarrays. Seventeen miRNAs were selected for validation via qRT-PCR based on the fol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiaoming, Wu, Baiqun, Fan, Jingjing, Han, Ruhui, Luo, Chen, Wang, Ting, Yang, Jingjin, Han, Lei, Zhu, Baoli, Wei, Dong, Chen, Jingyu, Ni, Chunhui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569899/ https://www.ncbi.nlm.nih.gov/pubmed/26370615 http://dx.doi.org/10.1038/srep14131

Ejemplares similares

Polymorphisms in interleukin 17A gene and coal workers’ pneumoconiosis risk in a Chinese population
por: Han, Ruhui, et al.
Publicado: (2015)

Polymorphisms in SPARC and Coal Workers' Pneumoconiosis Risk in a Chinese Population
por: Wang, Ting, et al.
Publicado: (2014)

Associations of MMP1, MMP2 and MMP3 Genes Polymorphism with Coal Workers’ Pneumoconiosis in Chinese Han Population
por: Ji, Xiaoming, et al.
Publicado: (2015)

miR-489 inhibits silica-induced pulmonary fibrosis by targeting MyD88 and Smad3 and is negatively regulated by lncRNA CHRF
por: Wu, Qiuyun, et al.
Publicado: (2016)

MiR-503 modulates epithelial-mesenchymal transition in silica-induced pulmonary fibrosis by targeting PI3K p85 and is sponged by lncRNA MALAT1
por: Yan, Weiwen, et al.
Publicado: (2017)

Prevalence Characteristics of Coal Workers’ Pneumoconiosis (CWP) in a State-Owned Mine in Eastern China
por: Han, Lei, et al.
Publicado: (2015)

MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
por: ElKhouly, Aisha M., et al.
Publicado: (2020)

Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults
por: Liu, Huang-Chun, et al.
Publicado: (2021)

MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
por: Fernández-Villabrille, Sara, et al.
Publicado: (2023)

Polymorphisms in Long Noncoding RNA H19 Contribute to the Protective Effects of Coal Workers’ Pneumoconiosis in a Chinese Population
por: Wu, Qiuyun, et al.
Publicado: (2016)

Polymorphisms in SELE Gene and Risk of Coal Workers' Pneumoconiosis in Chinese: A Case-Control Study
por: Wang, Ting, et al.
Publicado: (2013)

Polymorphisms in Inflammasome Genes and Risk of Coal Workers' Pneumoconiosis in a Chinese Population
por: Ji, Xiaoming, et al.
Publicado: (2012)

MicroRNA 486-3P as a stability marker in acute coronary syndrome
por: Wei, Tianling, et al.
Publicado: (2016)

LRBA Gene Polymorphisms and Risk of Coal Workers’ Pneumoconiosis: A Case–Control Study from China
por: Liu, Yi, et al.
Publicado: (2017)

MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells
por: Feng, Li, et al.
Publicado: (2018)

Microrna-486-5P Regulates Human Pulmonary Artery Smooth Muscle Cell Migration via Endothelin-1
por: Yen, Ting-An, et al.
Publicado: (2022)

Anti-fibrotic efficacy of nintedanib in pulmonary fibrosis via the inhibition of fibrocyte activity
por: Sato, Seidai, et al.
Publicado: (2017)

MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2015)

Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment
por: Cilli, Aykut, et al.
Publicado: (2023)

Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637
por: Zheng, Xiaotao, et al.
Publicado: (2021)

The In Vivo Fibrotic Role of FIZZ1 in Pulmonary Fibrosis
por: Liu, Tianju, et al.
Publicado: (2014)

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2016)

MicroRNA mimicry blocks pulmonary fibrosis
por: Montgomery, Rusty L, et al.
Publicado: (2014)

Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
por: Dempsey, Timothy M., et al.
Publicado: (2022)

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
por: Astor, Todd L., et al.
Publicado: (2023)

Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma
por: Faur, Cosmin Ioan, et al.
Publicado: (2022)

MicroRNA-486-5p inhibits the growth of human hypertrophic scar fibroblasts by regulating Smad2 expression
por: Shi, Yingying, et al.
Publicado: (2019)

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
por: Aoi, Wataru, et al.
Publicado: (2013)

Overexpression of microRNA-486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
por: Pinelli, Silvana, et al.
Publicado: (2021)

miR‐486 improves fibrotic activity in myocardial infarction by targeting SRSF3/p21‐Mediated cardiac myofibroblast senescence
por: Chen, Hongyi, et al.
Publicado: (2022)

MicroRNA-221 Is Cardioprotective and Anti-fibrotic in a Rat Model of Myocardial Infarction
por: Zhou, Yue, et al.
Publicado: (2019)

Uridine supplementation exerts anti-inflammatory and anti-fibrotic effects in an animal model of pulmonary fibrosis
por: Cicko, Sanja, et al.
Publicado: (2015)

The Interaction Between Pulmonary Fibrosis and COVID-19 and the Application of Related Anti-Fibrotic Drugs
por: Shen, Hao, et al.
Publicado: (2022)

Anti-fibrotic Treatment for Pulmonary Fibrosis Induced by COVID-19: A Case Presentation
por: Sakızcı Uyar, Bahar, et al.
Publicado: (2022)

Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
por: Khor, Yet H., et al.
Publicado: (2020)

Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression
por: Yang, N., et al.
Publicado: (2017)

MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
por: Chou, Sung-Tau, et al.
Publicado: (2019)

MicroRNAs as potential targets for progressive pulmonary fibrosis
por: Rajasekaran, Subbiah, et al.
Publicado: (2015)

Adipose-Derived Stem Cell-Derived Extracellular Vesicles Inhibit the Fibrosis of Fibrotic Buccal Mucosal Fibroblasts via the MicroRNA-375/FOXF1 Axis
por: Han, Bin, et al.
Publicado: (2021)

Fibrotic microtissue array to predict anti-fibrosis drug efficacy
por: Asmani, Mohammadnabi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ue69athm2nu4uqca8i022jlg3b